RecruitingNCT05714124

Liver Embolization Approaches for Tumor Management

Liver Embolization Approaches for Tumor Management - Retrospective and Prospective Analysis of the Short-, Medium-, and Long-term Clinical Course of Patients Subjected to Embolization Treatment for Primary and Secondary Liver Neoplasms


Sponsor

IRCCS San Raffaele

Enrollment

580 participants

Start Date

May 21, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration. This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • ≥ 18 yoa
  • patients with patients with primary or secondary liver disease not amenable for surgery or ablation
  • patients with primary or secondary liver tumors candidates for major surgery prior to induction of hypertrophy
  • able and willing to sign informed consent

Exclusion Criteria5

  • pregnant women
  • patients with uncorrectable coagulopathy
  • diffuse extrahepatic disease
  • for lobar TACE and TARE - presence of bilodigestive shunt
  • for TARE - \>20% hepatopulmonary shunt

Interventions

PROCEDUREEmbolization

Endovascular treatment for patients with primary and secondary liver tumors


Locations(1)

IRCCS Ospedale San Raffaele

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05714124


Related Trials